Pharma giant Bayer (BAYRY) announced a collaboration and license agreement with biotechnology company NextRNA Therapeutics.NextRNA Therapeutics is a biotechnology company focused on developing transformative medicines to address long non-coding RNA (lncRNA)-driven diseases with a primary focus on oncology and neuroscience.The collaboration is aimed at developing small molecule therapeutics targeting lncRNAs in oncology.Year to date, shares of Bayer have lost 16.8% against the industry’s growth of 26.9%.Imag ...